Home
Conditions
Hepatitis

Clinical trial condition

Hepatitis

Explore clinical trials studying Hepatitis. Study availability and eligibility vary by location and protocol.

2,969 public trials 189 recruiting studies

Refine in advanced search Browse all conditions

Hepatitis trial results

Completed

Comparison of Adjuvanted Hepatitis B Vaccine to Double Dose of Engerix™-B in Pre- /Haemodialysis Patients Aged ≥15 Years

NCT00383591

Conditions: Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
Locations: GSK Investigational Site Hradec Králové, Czechia

GSK Investigational Site Bandar Tun Razak, Cheras, Malaysia

GSK Investigational Site Barcelona, Spain

GSK Investigational Site Madrid, Spain

View Trial Details

Completed

Trial of Peg-interferon Plus Epoetin-alfa for Treatment of Chronic Hepatitis C Virus Infection

NCT00248339

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations: Virginia Commonwealth University Richmond, Virginia, United States

View Trial Details

Completed

Peginterferon Alpha-2a Maintenance Therapy for Portal Hypertension in Patients With Hepatitis C

NCT00252642

Conditions: Blood-Borne Infections, Cirrhosis, Communicable Diseases, +13 more
Locations: Virginia Commonwealth University Richmond, Virginia, United States

View Trial Details

Completed

A Study to Assess the Efficacy and Safety of the Combination of Simeprevir and Daclatasvir in Chronic Hepatitis C Genotype 1b-Infected Participants

NCT02268864

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: Antwerp, Belgium

Brussels, Belgium

Ghent, Belgium

Créteil, France

View all 23 locations

View Trial Details

Completed

Modified Process Hepatitis B Vaccine in Healthy Neonates (V232-056)

NCT00322361

Conditions: Adenocarcinoma, Blood-Borne Infections, Carcinoma, +18 more
Locations: Not specified

View Trial Details

Completed

Individualized Triple-therapy Using Boceprevir in HIV-positive Patients With Hepatitis C

NCT01925183

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +15 more
Locations: Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna Vienna, State of Vienna, Austria

View Trial Details

Completed

A Research Study to Test Safety, Tolerability, and Immunogenicity of a Recombinant Hepatitis B Vaccine Manufactured With an Upgrade to the Production Process (V232-054)

NCT00489099

Conditions: Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +9 more
Locations: Not specified

View Trial Details

Completed

Comparative Effectiveness and Tolerability of Boceprevir vs Telaprevir

NCT02113631

Conditions: Blood-Borne Infections, Chronic Disease, Cirrhosis, +16 more
Locations: Louis Stokes Cleveland VA medical center Cleveland, Ohio, United States

View Trial Details

Completed

Civacir® Polyclonal Immune Globulin (IgG) to Prevent Hepatitis C Virus (HCV) Recurrence in Liver Transplant Patients.

NCT01804829

Conditions: Adenocarcinoma, Blood-Borne Infections, Carcinoma, +24 more
Locations: University of Southern California / Keck Hospital Los Angeles, California, United States

University of California San Francisco San Francisco, California, United States

University of Miami Miller School of Medicine Miami, Florida, United States

Florida Hospital Transplant Institute Orlando, Florida, United States

View all 23 locations

View Trial Details

Completed

Quality of Life Therapy for Adults With Hepatitis C Virus and Cirrhosis Awaiting Liver Transplantation

NCT00794911

Conditions: Blood-Borne Infections, Chronic HCV, Communicable Diseases, +12 more
Locations: Beth Israel Deaconess Medical Center Boston, Massachusetts, United States

View Trial Details

Hepatitis

Hepatitis trial results

Related conditions